GROWLIFE, INC.
growlifeinc.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q2 FY2023 10-Q, filed Aug 23, 2024. Its latest SEC filing is a REVOKED from Dec 10, 2025.
10-Q for Q2 FY2023, filed Aug 23, 2024
The sections below describe the company as of the FY2022 annual report.
What Did They Do?
Focuses on functional mushroom opportunities, aiming to supply mushrooms to providers of mushroom-based products through its existing distribution channel.
10-K for FY2022, filed Jun 13, 2023The GrowLife executive team has focused on exploring new business alternatives for the Company and settlement on the EZ-CLONE litigation…View ↗
How Were They Changing?
-
Dec 7, 2023
MGO declined reappointment, and GrowLife appointed M&K as its new auditor
MGO cited no disagreements; the company noted internal-control weaknesses involving audit committee makeup and accounting and reporting governance.
Sources
8-K, filed Dec 7, 2023
On November 29, 2023, GrowLife, Inc. (the “Company”) received written notification from Marcias Gini & O’Connell LLP (“MGO”) of their…View ↗
From cloning to mushrooms
GrowLife described selling cloning systems and related products for cultivators; the latest report shifts its focus to functional mushrooms and providers of mushroom-based products.
10-K for FY2019, filed Apr 1, 2020 10-K for FY2022, filed Jun 13, 2023The GrowLife executive team has focused on exploring new business alternatives for the Company and settlement on the EZ-CLONE litigation…View ↗
Loading...
